A carregar...
Immune Checkpoint Inhibitors and Atherosclerotic Vascular Events in Cancer Patients
In clinical trials and meta-analysis, atherosclerotic vascular events (AVEs) during treatment with immune-checkpoint inhibitors (ICIs) have been reported with low incidence. However, preclinical data suggest that these drugs can promote atherosclerosis inflammation and progression of atherosclerosis...
Na minha lista:
| Publicado no: | Front Cardiovasc Med |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8193098/ https://ncbi.nlm.nih.gov/pubmed/34124192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2021.652186 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|